glp 1 new drug Retatrutide for weight loss: Study shows 30% body weight loss Popular GLP-1 medications may have
Description
Nat Metab 1, 5869 (2019)
GLP-1RAs and CVOTs Available GLP-1RAs (except for exenatide twice daily) have been examined in multicentre, double-blinded, randomised, placebo-controlled cardiovascular (CV) outcomes trials (CVOTs)
The search strategy for each database used the following terms: GLP-1 AND anesthesia, GLP-1 AND anesthesiology", GLP-1 AND aspiration, GLP-1 AND gastric emptying, GLP-1 AND gastric content, GLP-1 AND gastric residual, GLP-1 AND perioperative, GLP-1 AND surgical consideration, and GLP-1 AND surgical assessment" ( Supplemental File 1 )
Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP
It was also recently approved to reduce the risk of sustained kidney function decline in adults with type 2 diabetes and chronic kidney disease
